Clinically Relevant Resistance in Cancer Chemotherapy

Nonfiction, Health & Well Being, Medical, Specialties, Oncology
Cover of the book Clinically Relevant Resistance in Cancer Chemotherapy by , Springer US
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781461511731
Publisher: Springer US Publication: December 6, 2012
Imprint: Springer Language: English
Author:
ISBN: 9781461511731
Publisher: Springer US
Publication: December 6, 2012
Imprint: Springer
Language: English

Over the last several decades, the introduction of new chemotherapeutic drugs and drug combinations has resulted in increased long­ term remission rates in several important tumor types. These include childhood leukemia, adult leukemias and lymphomas, as well as testicular and trophoblastic tumors. The addition of high-dose chemotherapy with growth factor and hemopoietic stem cell support has increased clinical remission rates even further. For the majority of patients with some of the more common malignancies, however, palliation (rather than cure) is still the most realistic goal of chemotherapy for metastatic disease. The failure of chemotherapy to cure metastatic cancer is commonly referred to among clinicians as "drug resistance". This phenomenon can, however, often be viewed as the survival of malignant cells that resulted from a failure to deliver an effective drug dose to the (cellular) target because of anyone of or combination of a multitude of individual factors. Clinically, this treatment failure is often viewed as the rapid occurrence of resistance at the single cell level. However, in experimental systems, stable drug resistance is usually relatively slow to emerge.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Over the last several decades, the introduction of new chemotherapeutic drugs and drug combinations has resulted in increased long­ term remission rates in several important tumor types. These include childhood leukemia, adult leukemias and lymphomas, as well as testicular and trophoblastic tumors. The addition of high-dose chemotherapy with growth factor and hemopoietic stem cell support has increased clinical remission rates even further. For the majority of patients with some of the more common malignancies, however, palliation (rather than cure) is still the most realistic goal of chemotherapy for metastatic disease. The failure of chemotherapy to cure metastatic cancer is commonly referred to among clinicians as "drug resistance". This phenomenon can, however, often be viewed as the survival of malignant cells that resulted from a failure to deliver an effective drug dose to the (cellular) target because of anyone of or combination of a multitude of individual factors. Clinically, this treatment failure is often viewed as the rapid occurrence of resistance at the single cell level. However, in experimental systems, stable drug resistance is usually relatively slow to emerge.

More books from Springer US

Cover of the book English for Academic Research: Grammar Exercises by
Cover of the book CDMA Techniques for Third Generation Mobile Systems by
Cover of the book Principles of Food Processing by
Cover of the book Changing Families by
Cover of the book Clinical Physiology of the Venous System by
Cover of the book Computer Architecture: A Minimalist Perspective by
Cover of the book Problems and Solutions in Human Assessment by
Cover of the book Cancers of the Head and Neck by
Cover of the book Advances in Corrosion Science and Technology by
Cover of the book The Small GTPase Ran by
Cover of the book The Reconstruction of Natural Zeolites by
Cover of the book Ecological Principles of Nature Conservation by
Cover of the book Ovarian Cancer by
Cover of the book Design of Interconnection Networks for Programmable Logic by
Cover of the book Case Studies in Family Violence by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy